Abrdn World Healthcare Fund (NYSE:THW) Trading 0.6% Higher – Still a Buy?

Abrdn World Healthcare Fund (NYSE:THW)’s share price shot up 0.6% during mid-day trading on Wednesday . The company traded as high as $13.60 and last traded at $13.48. Approximately 162,893 shares changed hands during mid-day trading, an increase of 23% from the average daily volume of 132,066 shares. The stock had previously closed at $13.40.

Abrdn World Healthcare Fund Stock Up 0.6%

The business’s fifty day moving average price is $12.67 and its 200 day moving average price is $12.56.

Abrdn World Healthcare Fund Dividend Announcement

The business also recently disclosed a monthly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 23rd were given a dividend of $0.1167 per share. This represents a c) dividend on an annualized basis and a yield of 10.4%. The ex-dividend date was Tuesday, June 23rd.

Institutional Trading of Abrdn World Healthcare Fund

Hedge funds have recently added to or reduced their stakes in the stock. Advisory Services Network LLC bought a new stake in Abrdn World Healthcare Fund during the 3rd quarter worth $43,000. Ameriflex Group Inc. acquired a new stake in shares of Abrdn World Healthcare Fund during the third quarter valued at about $79,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of Abrdn World Healthcare Fund during the second quarter worth about $113,000. Mercer Global Advisors Inc. ADV bought a new stake in shares of Abrdn World Healthcare Fund during the fourth quarter worth about $157,000. Finally, HighTower Advisors LLC acquired a new position in shares of Abrdn World Healthcare Fund in the fourth quarter valued at approximately $168,000.

Abrdn World Healthcare Fund Company Profile

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.